UK biotech company has raised $105 million to expand gene-edited banana production.
2026-03-13 00:00
Source:
Freshplaza.com
Tropic, firma biotechnologiczna z siedzibą w Norwich, Wielka Brytania, pozyskała 105 milionów dolarów w rundzie finansowania Serii C, aby rozszerzyć komercyjną produkcję swoich odmian bananów oraz rozwijać inne uprawy. Runda została współprowadzona przez Forbion Bioeconomy Fund oraz Cortevę poprzez swoją jednostkę Corteva.
Freshplaza.com
FreshPlaza is one of the world's most well-known global media platforms for the fresh fruits and vegetables industry, providing its readers with the latest market developments and trends. The team of writers and editors source news from all over the world, and a daily newsletter is sent out with dedicated issues for North America, Latin America, Europe, Asia, Oceania, and Africa.
FreshPlaza is by nature an interactive concept that relies on the participation of its readers, where readers are encouraged to use the platform for publishing free press releases (500 words or less) and job advertisements.
Add comment
Commentary option available only for users with a subscription purchased




